ESTRATEST

Estratest Adverse Events Reported to the FDA Over Time

How are Estratest adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Estratest, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Estratest is flagged as the suspect drug causing the adverse event.

Most Common Estratest Adverse Events Reported to the FDA

What are the most common Estratest adverse events reported to the FDA?

Breast Cancer	242 (18.92%)
Breast Cancer Female	221 (17.28%)
Breast Cancer Metastatic	32 (2.5%)
Depression	30 (2.35%)
Pain	30 (2.35%)
Ovarian Cancer	19 (1.49%)
Breast Cancer In Situ	15 (1.17%)
Cerebrovascular Accident	15 (1.17%)
Anxiety	14 (1.09%)
Hot Flush	12 (.94%)
Oestrogen Receptor Assay Positive	12 (.94%)
	Show More
Pulmonary Embolism	12 (.94%)
Chest Pain	10 (.78%)
Myocardial Infarction	10 (.78%)
Nausea	10 (.78%)
Breast Disorder	9 (.7%)
Breast Mass	9 (.7%)
Progesterone Receptor Assay Positiv...	9 (.7%)
Mastectomy	8 (.63%)
Blood Pressure Increased	7 (.55%)
Cardiac Disorder	7 (.55%)
Deep Vein Thrombosis	7 (.55%)
Breast Cancer Stage I	6 (.47%)
Hypertension	6 (.47%)
Lymphoedema	6 (.47%)
Malignant Breast Lump Removal	6 (.47%)
Migraine	6 (.47%)
Radiotherapy	6 (.47%)
Road Traffic Accident	6 (.47%)
Systemic Lupus Erythematosus	6 (.47%)
Tremor	6 (.47%)
Arthralgia	5 (.39%)
Asthma	5 (.39%)
Biliary Tract Disorder	5 (.39%)
Biopsy	5 (.39%)
Biopsy Site Unspecified Abnormal	5 (.39%)
Bone Density Decreased	5 (.39%)
Breast Pain	5 (.39%)
Cholelithiasis	5 (.39%)
Death	5 (.39%)
Erythema	5 (.39%)
Fatigue	5 (.39%)
Gallbladder Cancer	5 (.39%)
Herpes Virus Infection	5 (.39%)
Injury	5 (.39%)
Ligament Sprain	5 (.39%)
Liver Injury	5 (.39%)
Neoplasm Malignant	5 (.39%)
Nosophobia	5 (.39%)
Rash	5 (.39%)
Scleroderma	5 (.39%)
Skin Burning Sensation	5 (.39%)
Skin Reaction	5 (.39%)
Tooth Extraction	5 (.39%)
Vascular Dementia	5 (.39%)
Appendicitis	4 (.31%)
Aspiration Breast	4 (.31%)
Blood Cholesterol Increased	4 (.31%)
Breast Cancer Recurrent	4 (.31%)
Breast Fibrosis	4 (.31%)
Cardiovascular Disorder	4 (.31%)
Chemotherapy	4 (.31%)
Dizziness	4 (.31%)
Headache	4 (.31%)
Loose Tooth	4 (.31%)
Mammogram Abnormal	4 (.31%)
Marital Problem	4 (.31%)
Muscle Strain	4 (.31%)
Radiation Skin Injury	4 (.31%)
Transient Ischaemic Attack	4 (.31%)
Agitation	3 (.23%)
Benign Intracranial Hypertension	3 (.23%)
Blood Oestrogen Abnormal	3 (.23%)
Blood Testosterone Decreased	3 (.23%)
Breast Reconstruction	3 (.23%)
Chills	3 (.23%)
Dehydration	3 (.23%)
Drug Ineffective	3 (.23%)
Influenza Like Illness	3 (.23%)
Lymphadenectomy	3 (.23%)
Muscle Tightness	3 (.23%)
Muscular Weakness	3 (.23%)
Osteopenia	3 (.23%)
Osteoporosis	3 (.23%)
Perforated Ulcer	3 (.23%)
Polycythaemia Vera	3 (.23%)
Product Substitution Issue	3 (.23%)
Pulmonary Congestion	3 (.23%)
Thyroid Neoplasm	3 (.23%)
Vaginal Haemorrhage	3 (.23%)
Visual Impairment	3 (.23%)
Abortion Spontaneous	2 (.16%)
Acne	2 (.16%)
Alopecia	2 (.16%)
Asthenia	2 (.16%)
Back Pain	2 (.16%)
Balance Disorder	2 (.16%)
Basal Cell Carcinoma	2 (.16%)
Biopsy Breast	2 (.16%)
Biopsy Skin	2 (.16%)
Breast Operation	2 (.16%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Estratest, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Estratest is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Estratest

What are the most common Estratest adverse events reported to the FDA?

Breast Neoplasms Malignant And Unsp...	520 (40.66%)
Breast	30 (2.35%)
Depressed Mood Disorders	30 (2.35%)
Endocrine Investigations	27 (2.11%)
Injuries	27 (2.11%)
Epidermal And Dermal Conditions	26 (2.03%)
Anxiety Disorders	23 (1.8%)
Central Nervous System Vascular	20 (1.56%)
Reproductive Neoplasms Female Malig...	20 (1.56%)
Breast Therapeutic Procedures	19 (1.49%)
Cardiac Disorder Signs	13 (1.02%)
	Show More
Gastrointestinal Signs	13 (1.02%)
Skin Appendage Conditions	13 (1.02%)
Cardiac And Vascular Investigations	12 (.94%)
Pulmonary Vascular	12 (.94%)
Therapeutic Procedures And Supporti...	12 (.94%)
Vascular	12 (.94%)
Connective Tissue Disorders	11 (.86%)
Investigations, Imaging And Histopa...	11 (.86%)
Neurological	11 (.86%)
Coronary Artery	10 (.78%)
Headaches	10 (.78%)
Joint	10 (.78%)
Reproductive Organ And Breast Inves...	10 (.78%)
Muscle	9 (.7%)
Infections - Pathogen Unspecified	8 (.63%)
Vision	8 (.63%)
Bone Disorders	7 (.55%)
Embolism And Thrombosis	7 (.55%)
Head And Neck Therapeutic Procedure...	7 (.55%)
Therapeutic And Nontherapeutic Effe...	7 (.55%)
Dental And Gingival Conditions	6 (.47%)
Electrolyte And Fluid Balance Condi...	6 (.47%)
Gallbladder	6 (.47%)
Injuries By Physical Agents	6 (.47%)
Lymphatic Vessel	6 (.47%)
Miscellaneous And Site Unspecified ...	6 (.47%)
Movement Disorders	6 (.47%)
Musculoskeletal And Connective Tiss...	6 (.47%)
Vascular Hypertensive	6 (.47%)
Viral Infectious	6 (.47%)
Bile Duct	5 (.39%)
Bronchial Disorders	5 (.39%)
Fatal Outcomes	5 (.39%)
Hematology Investigations	5 (.39%)
Hepatic And Hepatobiliary	5 (.39%)
Hepatobiliary	5 (.39%)
Hepatobiliary Neoplasms Malignant A...	5 (.39%)
Medication Errors	5 (.39%)
Mental Impairment	5 (.39%)
Mood Disorders	5 (.39%)
Musculoskeletal And Soft Tissue Inv...	5 (.39%)
Product Quality Issues	5 (.39%)
Respiratory	5 (.39%)
Cutaneous Neoplasms Benign	4 (.31%)
Family Issues	4 (.31%)
Lipid Analyses	4 (.31%)
Spleen, Lymphatic And Reticulendoth...	4 (.31%)
Tissue	4 (.31%)
Vulvovaginal Disorders	4 (.31%)
Abortions And Stillbirth	3 (.23%)
Chemical Injury And Poisoning	3 (.23%)
Endocrine Neoplasms Malignant And U...	3 (.23%)
Gastrointestinal Motility And Defec...	3 (.23%)
Hematological And Lymphoid Tissue T...	3 (.23%)
Hematopoietic Neoplasms	3 (.23%)
Increased Intracranial Pressure And...	3 (.23%)
Lower Respiratory Tract Disorders	3 (.23%)
Menopause And Related Conditions	3 (.23%)
Procedural And Device Related Injur...	3 (.23%)
Sleep Disorders	3 (.23%)
Administration Site Reactions	2 (.16%)
Body Temperature Conditions	2 (.16%)
Cardiac Arrhythmias	2 (.16%)
Cardiac Valve	2 (.16%)
Eye Disorders Congenital	2 (.16%)
Fungal Infectious	2 (.16%)
Gastrointestinal Hemorrhages	2 (.16%)
Gastrointestinal Inflammatory Condi...	2 (.16%)
Manic And Bipolar Mood Disorders	2 (.16%)
Myocardial	2 (.16%)
Oral Soft Tissue Conditions	2 (.16%)
Personality Disorders	2 (.16%)
Physical Examination Topics	2 (.16%)
Respiratory And Pulmonary Investiga...	2 (.16%)
Retina, Choroid And Vitreous Hemorr...	2 (.16%)
Skin	2 (.16%)
Skin Neoplasms Malignant And Unspec...	2 (.16%)
Skin Vascular Abnormalities	2 (.16%)
Anal And Rectal Conditions	1 (.08%)
Anemias Nonhemolytic And Marrow Dep...	1 (.08%)
Appetite And General Nutritional	1 (.08%)
Aural	1 (.08%)
Bone And Joint Injuries	1 (.08%)
Bone And Joint Therapeutic Procedur...	1 (.08%)
Breast Neoplasms Benign	1 (.08%)
Central Nervous System Infections A...	1 (.08%)
Changes In Physical Activity	1 (.08%)
Disturbances In Thinking	1 (.08%)
Diverticular	1 (.08%)
Economic And Housing Issues	1 (.08%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Estratest, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Estratest is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.